总时间（秒）：13.11
问答时间（秒）：11.32

Based on the provided literature, I will extract and standardize the information according to the predefined JSON framework.

Here is the extracted and standardized information:

```
{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_005045.2:c.59A>T",
          "cDNA Change": {
            "transcript": "NM_005045.2",
            "ref": "A",
            "alt": "T",
            "position": "59"
          },
          "Protein Change": {
            "ref": "D",
            "alt": "V",
            "position": "20"
          },
          "Description in input context": "A53T"
        },
        {
          "HGVS": "NM_005045.2:c.88C>A",
          "cDNA Change": {
            "transcript": "NM_005045.2",
            "ref": "C",
            "alt": "A",
            "position": "88"
          },
          "Protein Change": {
            "ref": "P",
            "alt": "Q",
            "position": "30"
          },
          "Description in input context": "A30P"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005410"
  },
  "Experiment Method": [
    {
      "Assay Method": "Binding assay",
      "Material used": {
        "Material Source": "Human R-synuclein protein",
        "Material Name": "Wild-type SNCA and mutant SNCA (A30P and A53T)",
        "Description": "The experiment was conducted using human R-synuclein protein."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_005045.2:c.59A>T",
          "Conclusion": "Normal",
          "Molecular Effect": "N.D.",
          "Result Description": "Cu(II) binding to wild-type SNCA and mutant SNCA (A53T) at 37 °C is similar."
        },
        {
          "Variant": "NM_005045.2:c.88C>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "N.D.",
          "Result Description": "Cu(II) binding to mutant SNCA (A30P) at 37 °C is different from wild-type SNCA and A53T."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type SNCA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "No"
      }
    }
  ]
}
```

Note that the `Approved assay` field is set to "No" because the experimental protocol used in the literature may not be generally used for studying Parkinson's disease. However, this depends on the specific context and requirements of the study.